Teva Pharmaceutical Industries Limited (TEVA)
USD 21.2
(1.53%)
USD 21.2
(1.53%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 4.45 Billion USD | 3.92% |
| 2022 | 4.28 Billion USD | -4.72% |
| 2021 | 4.49 Billion USD | -3.71% |
| 2020 | 4.66 Billion USD | -3.07% |
| 2019 | 4.81 Billion USD | -11.26% |
| 2018 | 5.42 Billion USD | -20.59% |
| 2017 | 6.83 Billion USD | -5.18% |
| 2016 | 7.2 Billion USD | 15.46% |
| 2015 | 6.24 Billion USD | -4.93% |
| 2014 | 6.56 Billion USD | -2.67% |
| 2013 | 6.74 Billion USD | 4.22% |
| 2012 | 6.47 Billion USD | 17.58% |
| 2011 | 5.5 Billion USD | 15.51% |
| 2010 | 4.76 Billion USD | 10.81% |
| 2009 | 4.3 Billion USD | -10.82% |
| 2008 | 4.82 Billion USD | 94.32% |
| 2007 | 2.48 Billion USD | 14.75% |
| 2006 | 2.16 Billion USD | 85.24% |
| 2005 | 1.16 Billion USD | 9.65% |
| 2004 | 1.06 Billion USD | 67.94% |
| 2003 | 634.1 Million USD | 10.97% |
| 2002 | 571.4 Million USD | 21.36% |
| 2001 | 470.83 Million USD | 14.38% |
| 2000 | 411.65 Million USD | 7.16% |
| 1999 | 384.15 Million USD | 14.74% |
| 1998 | 334.8 Million USD | 6.56% |
| 1997 | 314.2 Million USD | 14.63% |
| 1996 | 274.1 Million USD | 45.49% |
| 1995 | 188.4 Million USD | 7.47% |
| 1994 | 175.3 Million USD | 20.48% |
| 1993 | 145.5 Million USD | 20.35% |
| 1992 | 120.9 Million USD | 49.44% |
| 1991 | 80.9 Million USD | -16.94% |
| 1990 | 97.4 Million USD | 73.31% |
| 1989 | 56.2 Million USD | -4.91% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 1.12 Billion USD | -0.09% |
| 2024 Q2 | 1.2 Billion USD | 7.09% |
| 2023 Q2 | 1.15 Billion USD | 6.88% |
| 2023 Q1 | 1.07 Billion USD | 2.67% |
| 2023 FY | 4.45 Billion USD | 3.92% |
| 2023 Q4 | 1.12 Billion USD | 2.92% |
| 2023 Q3 | 1.09 Billion USD | -4.61% |
| 2022 Q3 | 997 Million USD | -12.16% |
| 2022 Q1 | 1.1 Billion USD | -4.08% |
| 2022 FY | 4.28 Billion USD | -4.72% |
| 2022 Q2 | 1.13 Billion USD | 2.71% |
| 2022 Q4 | 1.04 Billion USD | 5.12% |
| 2021 Q3 | 1.11 Billion USD | 0.45% |
| 2021 FY | 4.49 Billion USD | -3.71% |
| 2021 Q2 | 1.1 Billion USD | -2.13% |
| 2021 Q4 | 1.15 Billion USD | 3.78% |
| 2021 Q1 | 1.12 Billion USD | -13.35% |
| 2020 FY | 4.66 Billion USD | -3.07% |
| 2020 Q3 | 1.14 Billion USD | 5.16% |
| 2020 Q4 | 1.3 Billion USD | 14.1% |
| 2020 Q2 | 1.08 Billion USD | -4.57% |
| 2020 Q1 | 1.13 Billion USD | -9.39% |
| 2019 Q2 | 1.23 Billion USD | 3.08% |
| 2019 FY | 4.81 Billion USD | -11.26% |
| 2019 Q1 | 1.2 Billion USD | -16.36% |
| 2019 Q3 | 1.12 Billion USD | -9.53% |
| 2019 Q4 | 1.25 Billion USD | 12.14% |
| 2018 FY | 5.42 Billion USD | -20.59% |
| 2018 Q1 | 1.41 Billion USD | -17.47% |
| 2018 Q2 | 1.31 Billion USD | -7.13% |
| 2018 Q4 | 1.43 Billion USD | 5.36% |
| 2018 Q3 | 1.36 Billion USD | 3.57% |
| 2017 Q2 | 1.71 Billion USD | 3.25% |
| 2017 Q4 | 1.71 Billion USD | -1.04% |
| 2017 Q3 | 1.73 Billion USD | 0.99% |
| 2017 FY | 6.83 Billion USD | -5.18% |
| 2017 Q1 | 1.66 Billion USD | -21.66% |
| 2016 FY | 7.2 Billion USD | 15.46% |
| 2016 Q1 | 1.53 Billion USD | -7.32% |
| 2016 Q2 | 1.63 Billion USD | 6.92% |
| 2016 Q3 | 1.91 Billion USD | 16.79% |
| 2016 Q4 | 2.12 Billion USD | 11.03% |
| 2015 Q4 | 1.65 Billion USD | 13.45% |
| 2015 FY | 6.24 Billion USD | -4.93% |
| 2015 Q3 | 1.45 Billion USD | -7.26% |
| 2015 Q2 | 1.57 Billion USD | 0.64% |
| 2015 Q1 | 1.56 Billion USD | -8.45% |
| 2014 Q3 | 1.65 Billion USD | 5.62% |
| 2014 FY | 6.56 Billion USD | -2.67% |
| 2014 Q1 | 1.63 Billion USD | -11.83% |
| 2014 Q2 | 1.56 Billion USD | -4.39% |
| 2014 Q4 | 1.7 Billion USD | 3.02% |
| 2013 Q3 | 1.61 Billion USD | -1.46% |
| 2013 FY | 6.74 Billion USD | 4.22% |
| 2013 Q1 | 1.63 Billion USD | -10.19% |
| 2013 Q2 | 1.64 Billion USD | 0.55% |
| 2013 Q4 | 1.85 Billion USD | 15.04% |
| 2012 Q1 | 1.53 Billion USD | -11.8% |
| 2012 Q4 | 1.81 Billion USD | 18.69% |
| 2012 Q3 | 1.53 Billion USD | -4.08% |
| 2012 Q2 | 1.59 Billion USD | 4.11% |
| 2012 FY | 6.47 Billion USD | 17.58% |
| 2011 FY | 5.5 Billion USD | 15.51% |
| 2011 Q4 | 1.73 Billion USD | 51.7% |
| 2011 Q1 | 1.29 Billion USD | -4.23% |
| 2011 Q2 | 1.6 Billion USD | 24.07% |
| 2011 Q3 | 1.14 Billion USD | -28.57% |
| 2010 Q1 | 1.14 Billion USD | -3.7% |
| 2010 FY | 4.76 Billion USD | 10.81% |
| 2010 Q4 | 1.34 Billion USD | 10.03% |
| 2010 Q3 | 1.22 Billion USD | 16.76% |
| 2010 Q2 | 1.05 Billion USD | -8.3% |
| 2009 Q2 | 1.06 Billion USD | 4.71% |
| 2009 Q1 | 1.01 Billion USD | -55.64% |
| 2009 FY | 4.3 Billion USD | -10.82% |
| 2009 Q3 | 1.07 Billion USD | 1.03% |
| 2009 Q4 | 1.18 Billion USD | 10.3% |
| 2008 Q2 | 867 Million USD | 25.11% |
| 2008 Q4 | 2.29 Billion USD | 172.8% |
| 2008 FY | 4.82 Billion USD | 94.32% |
| 2008 Q1 | 693 Million USD | 1.02% |
| 2008 Q3 | 842 Million USD | -2.88% |
| 2007 Q4 | 686 Million USD | 14.52% |
| 2007 Q1 | 591 Million USD | -13.06% |
| 2007 FY | 2.48 Billion USD | 14.75% |
| 2007 Q2 | 606 Million USD | 2.54% |
| 2007 Q3 | 599 Million USD | -1.16% |
| 2006 Q3 | 538.1 Million USD | 8.47% |
| 2006 Q1 | 418.4 Million USD | 32.7% |
| 2006 FY | 2.16 Billion USD | 85.24% |
| 2006 Q4 | 679.8 Million USD | 26.33% |
| 2006 Q2 | 496.1 Million USD | 18.57% |
| 2005 Q1 | 272.8 Million USD | -2.78% |
| 2005 Q4 | 315.3 Million USD | 2.9% |
| 2005 Q3 | 306.4 Million USD | 12.15% |
| 2005 Q2 | 273.2 Million USD | 0.15% |
| 2005 FY | 1.16 Billion USD | 9.65% |
| 2004 Q2 | 256.2 Million USD | 0.0% |
| 2004 FY | 1.06 Billion USD | 67.94% |
| 2004 Q4 | 280.6 Million USD | 3.2% |
| 2004 Q3 | 271.9 Million USD | 6.13% |
| 2004 Q1 | 256.2 Million USD | 24.07% |
| 2003 Q1 | 169.1 Million USD | 7.98% |
| 2003 Q4 | 206.5 Million USD | 14.66% |
| 2003 FY | 634.1 Million USD | 10.97% |
| 2003 Q3 | 180.1 Million USD | 129.72% |
| 2003 Q2 | 78.4 Million USD | -53.64% |
| 2002 Q3 | 149 Million USD | 9.96% |
| 2002 Q2 | 135.5 Million USD | 3.99% |
| 2002 Q4 | 156.6 Million USD | 5.1% |
| 2002 Q1 | 130.3 Million USD | 1.69% |
| 2002 FY | 571.4 Million USD | 21.36% |
| 2001 Q1 | 118.05 Million USD | -5.34% |
| 2001 Q3 | 106.7 Million USD | -9.5% |
| 2001 Q2 | 117.89 Million USD | -0.14% |
| 2001 FY | 470.83 Million USD | 14.38% |
| 2001 Q4 | 128.13 Million USD | 20.09% |
| 2000 Q1 | 81.58 Million USD | -48.84% |
| 2000 FY | 411.65 Million USD | 7.16% |
| 2000 Q3 | 105.91 Million USD | -14.63% |
| 2000 Q4 | 124.72 Million USD | 17.76% |
| 2000 Q2 | 124.05 Million USD | 52.06% |
| 1999 Q2 | 76.1 Million USD | 5.84% |
| 1999 Q1 | 71.9 Million USD | -44.56% |
| 1999 Q4 | 159.45 Million USD | 107.63% |
| 1999 FY | 384.15 Million USD | 14.74% |
| 1999 Q3 | 76.8 Million USD | 0.92% |
| 1998 Q1 | 62.5 Million USD | 106.63% |
| 1998 FY | 334.8 Million USD | 6.56% |
| 1998 Q2 | 65.1 Million USD | 4.16% |
| 1998 Q3 | 77.6 Million USD | 19.2% |
| 1998 Q4 | 129.7 Million USD | 67.14% |
| 1997 Q2 | - USD | 0.0% |
| 1997 FY | 314.2 Million USD | 14.63% |
| 1997 Q3 | - USD | 0.0% |
| 1997 Q4 | -943.1 Million USD | 0.0% |
| 1997 Q1 | - USD | 100.0% |
| 1996 Q4 | -824.5 Million USD | 0.0% |
| 1996 Q3 | - USD | 0.0% |
| 1996 Q2 | - USD | 0.0% |
| 1996 Q1 | - USD | 100.0% |
| 1996 FY | 274.1 Million USD | 45.49% |
| 1995 Q1 | - USD | 100.0% |
| 1995 Q3 | - USD | 0.0% |
| 1995 Q2 | - USD | 0.0% |
| 1995 FY | 188.4 Million USD | 7.47% |
| 1995 Q4 | -552.5 Million USD | 0.0% |
| 1994 Q1 | - USD | 100.0% |
| 1994 FY | 175.3 Million USD | 20.48% |
| 1994 Q4 | -481 Million USD | 0.0% |
| 1994 Q3 | - USD | 0.0% |
| 1994 Q2 | - USD | 0.0% |
| 1993 Q4 | -414 Million USD | 0.0% |
| 1993 Q3 | - USD | 0.0% |
| 1993 Q1 | - USD | 100.0% |
| 1993 FY | 145.5 Million USD | 20.35% |
| 1993 Q2 | - USD | 0.0% |
| 1992 Q4 | -350.7 Million USD | 0.0% |
| 1992 Q2 | - USD | 0.0% |
| 1992 Q1 | - USD | 100.0% |
| 1992 Q3 | - USD | 0.0% |
| 1992 FY | 120.9 Million USD | 49.44% |
| 1991 Q2 | - USD | 0.0% |
| 1991 Q4 | -275 Million USD | 0.0% |
| 1991 Q1 | - USD | 100.0% |
| 1991 Q3 | - USD | 0.0% |
| 1991 FY | 80.9 Million USD | -16.94% |
| 1990 FY | 97.4 Million USD | 73.31% |
| 1990 Q1 | - USD | 100.0% |
| 1990 Q2 | - USD | 0.0% |
| 1990 Q3 | - USD | 0.0% |
| 1990 Q4 | -288.7 Million USD | 0.0% |
| 1989 Q3 | - USD | 0.0% |
| 1989 Q2 | - USD | 0.0% |
| 1989 Q1 | - USD | 100.0% |
| 1989 Q4 | -236.9 Million USD | 0.0% |
| 1989 FY | 56.2 Million USD | -4.91% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Amneal Pharmaceuticals, Inc. | 616.19 Million USD | -622.341% |
| Bausch Health Companies Inc. | 5.23 Billion USD | 14.976% |
| Catalent, Inc. | 1.7 Billion USD | -161.516% |
| Emergent BioSolutions Inc. | 1.04 Billion USD | -326.341% |
| Elanco Animal Health Incorporated | 1.61 Billion USD | -176.117% |
| Perrigo Company plc | 1.52 Billion USD | -191.201% |
| Zoetis Inc. | 2.76 Billion USD | -60.976% |